Tumor necrosis factor (TNF) is a highly pleiotropic cytokine whose activity is at least partially regulated by the redox status of the cell. The cellular redox status is controlled primarily by glutathione, a major cellular antioxidant, whose synthesis is regulated by the ratelimiting enzyme g-glutamylcysteine synthetase (g-GCS).
Introduction
Among cytokines, tumor necrosis factor (TNF) is one of the most multifaceted, as it is known to regulate abnormal cell growth, viral replication, in¯ammation, septic shock syndrome, immunomodulation, angiogenesis, and growth of bacteria, fungus, and parasites (for review see Aggarwal and Natarajan, 1996) . The eects of TNF are mediated primarily through two distinct receptors, the p60 receptor, which is expressed on all cell types, and the p80 receptor, which is expressed by only immune and endothelial cells (for references see review Darnay and Aggarwal, 1997) . Most TNF eects are mediated through the p60 receptor via the death domain but when the p80 receptor, which lacks the death domain, is appropriately expressed, it can mediate responses similar to those of p60 (Haridas et al., 1998 and references therein) .
The death domain present in the cytoplasmic portion of the p60 receptor has recently been shown to interact with almost 20 distinct proteins (Darnay and Aggarwal, 1997) that are involved in TNF-induced activation of apoptosis, induction of the transcription factors NF-kB and AP-1, and stimulation of stressactivated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) and mitogen-activated protein kinases (MAPK). The role of the receptor-interacting proteins in TNF signaling was established either by overexpression of the appropriate genes, by use of the dominant-negative mutants of these gene products, by coprecipitation of the signaling components, or by deletion in mice of a gene for the speci®c signaling protein (Darnay and Aggarwal, 1997; Tewari and Dixit, 1996) . These approaches have yielded a description of TNF signaling cascade. This cascade, however, does not account for the role of ceramide, reactive oxygen intermediates (ROI), phospholipases, serine proteases or protein tyrosine phosphatases and kinases previously implicated in TNF signaling (Aggarwal and Natarajan, 1996; Vandenabeele et al., 1995) .
Several reports indicate that TNF mediates most of its eects by altering the redox state of the cell (Schulze-Ostho et al., 1992; Ishi et al., 1992; Shoji et al., 1995; Goossens et al., 1995 Goossens et al., , 1996 Zamzami et al., 1995; Phelps et al., 1995; Mehlen et al., 1996; Obrador et al., 1997; Fernandez-Checa et al., 1997; Morales et al., 1997; Liu et al., 1998; Kinscherf et al., 1998) . Some reports suggest that TNF produces ROI, which in turn oxidizes intracellular glutathione, a critical change for TNF-induced apoptosis and NFkB activation Staal et al., 1990; Shreck et al., 1991 Shreck et al., , 1992a Anderson et al., 1994; Garcia-Ruiz et al., 1995) . Because mitochondria are the major sources of cellular ROI, the inhibitors of mitochondrial electron transport chain and respiration-de®cient cells diminish the TNF-induced signaling (Schultz-Ostho et al., 1992 Shoji et al., 1995; Zamzami et al., 1995; Goossens et al., 1996; Fernandez-Checa et al., 1997; Higuchi et al., 1997) . Similarly, such agents as dithiothreitol (DTT), pyrrolidine dithiocarbamate (PDTC), butylated hydroxyanisol (BHA), cysteine, and N-acetylcysteine (NAC), all of which increase extracellular GSH levels, have been shown to protect cells from TNF-induced apoptosis (Shoji et al., 1995; Goossens et al., 1995 , Obrador et al., 1997 Fernandez-Checa et al., 1997; Morales et al., 1997; Liu et al., 1998; Kinscherf et al., 1998) and inhibit NF-kB activation Staal et al., 1990; Schreck et al., 1991 Schreck et al., , 1992a Anderson et al., 1994) , whereas buthionine-L-sulfoximine (BSO), diethyl maleate (DEM), and 1,3-bis (chloroethyl)-1-nitrosourea (BCNU), which lower GSH levels potentiate the eects of TNF (Sen et al., 1997; Obrador et al., 1997; Garcia-Ruiz et al., 1995; Higuchi et al., 1997) .
Most of these studies were based on using metabolic inhibitors, which alter the redox state of the cells. Although convenient, metabolic inhibitors tend to be toxic, are poorly soluble and exhibit cell permeability problems, and are not always speci®c enough to provide conclusive and reproducible results.
An alternate way to experimentally alter the redox status is to use glutathione (GSH), the most prominent D Figure 1 (a) Eect of expression of g-GCS gene on TNF-dependent activation of NF-kB. Rat hepatoma (H-4-II-E) cells (2610 6 /ml), nontransfected and transfected with neo and g-GCS genes, were incubated at 378C with dierent concentrations of TNF for 30 min, and then nuclear extracts were prepared and assayed for NF-kB as described in Materials and methods. (b) Supershift and speci®city of NF-kB. Nuclear extracts were prepared from TNF (1 nM)-treated neo cells (2610 6 /ml), incubated for 15 min with dierent antibodies or unlabeled wild-type and mutated NF-kB oligo probe, and then assayed for NF-kB as described. (c) Time course of inhibition of TNF-dependent NF-kB by g-GCS. Rat hepatoma cells (2610 6 /ml), neo or g-GCS-transfected (clone 9), were incubated at 378C either with or without 1 nM TNF for indicated times. After these treatments nuclear extracts were prepared and then assayed for NF-kB as described in the Materials and methods. (d) Eect of g-GCS overexpression on constitutive levels of NF-kB (upper panel) and Sp1 (lower panel) as determined by DNA binding, and by Western blot analysis (middle panel). For upper panel, cell extracts were prepared from neo or g-GCS-transfected (clone 9) hepatoma cells (2610 6 /ml), treated with 0.8% deoxycholate and then examined for NF-kB DNA-binding by EMSA as described in the Materials and methods. For middle panel, cell extracts were examined for p50 and p65 by Western blot analysis. For lower panel, nuclear extracts were prepared from untreated and TNF-treated neo or g-GCS-transfected (clone 9) hepatoma cells (2610 6 /ml) and then examined for Sp1 DNAbinding by EMSA as described in the Materials and methods g-Glutamylcysteine synthetase suppresses TNF signaling SK Manna et al antioxidant in the cell and a major player in the protection from oxidative stress (Higuchi et al., 1997; Berlett and Stadtman, 1997; Droge et al., 1994; Meister, 1988a,b) . Cellular GSH is synthesized from its constituent amino acids in two sequential enzymatic reactions, ®rst catalyzed by a rate-limiting enzyme gglutamylcysteine synthetase (g-GCS) and second by GSH synthetase (Meister, 1988a,b) . g-GCS activity is inhibited by GSH through a feedback mechanism and by BSO (Meister, 1988b) . Thus intracellular GSH depletion is induced by either BSO or BCNU, an inhibitor of GSH reductase. g-GCS consists of a light chain and a heavy chain. The catalytic activity resides in the heavy chain whereas the light chain has regulatory function (Gipp et al., 1992; Huang et al., 1993a,b; Seelig et al., 1984) . The promoter region of the gene for heavy chain has been shown to possess binding sites for AP-1, AP-2, antioxidant response elements (ARE), metal response regulatory elements (MRE), and NF-kB. An AP-1 binding site has been found to be essential for its expression Mulcahy et al., 1997) .
Because of the importance in TNF signaling of redox status in general and GSH in particular, we undertook an investigation of the eect of g-GCS overexpression on TNF-induced signaling. Our results show that the activation of NF-kB, AP-1, JNK, MEK, caspase-3 and cytotoxicity all induced by TNF are abolished by overexpression of g-GCS, thus suggesting a critical role of the redox status of the cell in all major signals transduced by TNF. NF-kB activation induced by phorbol ester and okadaic acid was also eliminated, whereas that induced by H 2 O 2 , ceramide, and lipopolysaccharide were minimally aected, suggesting a dierence in signaling pathways.
Results
The aim of this study was to investigate the eect of the rate-limiting enzyme in GSH biosynthesis, g-GCS, on TNF-induced signaling. We stably transfected the cells with the g-GCS gene, selected the clones by neomycin treatment, and then analysed the cells for glutathione content. Transfected cells indeed expressed higher levels of glutathione than the neo control. These cells were then examined for TNFinduced activation of NF-kB, AP-1, JNK, MEK, and apoptosis. We also examined the eect of this gene on NF-kB activation induced by a wide variety of other agents. For all studies, untransfected cells and those transfected with neo gene were used as a control. Two dierent clones, 9 and 17 with variable Figure 2 Eect of g-GCS on NF-kB activation by PMA, serumactivated LPS, H 2 O 2 , okadaic acid, and ceramide. U-937 or rat hepatoma cells (2610 6 /ml), neo and g-GCS-transfected (clone 9), were pre-incubated with PMA (25 ng/ml), SA-LPS (10 mg/ml), H 2 O 2 (250 mM), okadaic acid (500 nM), or ceramide (10 mM) for 30 min and then tested for NF-kB as described Figure 3 Eect of g-GCS on TNF-induced degradation of IkBa and on the nuclear translocation of p65 subunit of NF-kB. Rat hepatoma cells (2610 6 /ml), neo and g-GCS-transfected (clone 9), were incubated for dierent times with TNF (1 nM) and then assayed for IkBa in cytosolic fractions by Western blot analysis (a) and for p65 in cytoplasmic and nuclear extracts by Western blot analysis (b) expression of g-GCS, were studied. Clone 9 was used for the majority of the experiments. When examined for TNF receptors, there was no dierence found in the speci®c binding of TNF (15773+771 vs 14447+562 c.p.m.) between neo and g-GCS-transfected cells (clone 9).
g-GCS inhibits TNF-induced NF-kB activation
Nontransfected and neo-and g-GCS-transfected rat hepatoma cells were stimulated with dierent concentrations of TNF and nuclear extracts were prepared and assayed for NF-kB by EMSA. As little as 100 pM TNF activated NF-kB in both nontransfected and neo-transfected cells. NF-kB was fully activated in clone 17 cells, which express a low level of g-GCS. In contrast, in clone 9, which expresses a signi®cant amount of g-GCS, NF-kB activation was completely abolished, even at 1000 pM TNF concentration ( Figure 1a) .
NF-kB exists in its inactive state in the cytoplasm as a complex consisting of p50, p65, and IkBa. When activated, IkBa undergoes phosphorylation, ubiquitination and degradation (for references see Baeuerle and Baichwal, 1997) . To determine the composition of activated NF-kB, nuclear extracts were incubated with antibodies to either p50 or p65 and then analysed by EMSA. That antibodies against either the p50 or p65 subunits supershifted the NF-kB bands ( Figure 1b) suggests that NF-kB suppressed by g-GCS consisted of p50 and p65 subunits. This supershift was speci®c, as the irrelevant antibodies to c-Rel or cyclin D1 or preimmune serum (PIS) had no eect. Speci®city was also indicated by the disappearance of this band when unlabeled probe was used and its persistence when the oligonucleotide with mutated NF-kB site was used ( Figure 1b ). Since no dierence was noted between nontransfected and neo-transfected rat hepatoma cells, for all following experiments only neo-transfected cells were used as a control.
In neo-transfected cells, TNF activated NF-kB within 15 min, and its level reached sixfold over the basal levels within 30 min ( Figure 1c ). In contrast, no signi®cant NF-kB activation was observed even after 1 h in g-GCS-transfected cells. At 2 h, there was twofold activation in the g-GCS-transfected cells.
It is possible that g-GCS-transfected cells as compare to neo cells show decrease in TNF-induced NF-kB activation because they contain lower constitutive levels of NF-kB protein. To investigate this possibility, we examined the level of constitutive NFkB by DNA binding and by Western blot analysis. Treatment of cell extracts with deoxycholate is known to dissociate the p50 and p65 heterodimer from IkBa, thus allowing its binding to the DNA. Our results show that the amount of NF-kB consisting of p50 and p65 is unchanged between neo and g-GCS-overexpressing cells as determined by DNA binding (Figure 1d , upper panel) or by Western blot analysis ( Figure 1d , middle panel). To demonstrate that the nuclear extracts from TNF-treated neo or g-GCS overexpressing cells are competent, we examined their binding to Sp1 (Figure 1d , lower panel). These results showed no dierence in the ability of either nuclear extracts to bind to Sp1.
g-GCS inhibits NF-kB activation induced by a wide variety of agents
Dierent agents may activate NF-kB by dierent mechanisms (Suzuki et al., 1994; Bowie et al., 1997; Bonizzi et al., 1996) . For instance NAC blocks TNF-and PMA-induced NF-kB but not that induced by okadaic acid (Suzuki et al., 1994) . Similarly lipid peroxidation is needed for TNF-but not IL-1 induced NF-kB activation (Bowie et al., 1997) . Therefore, we examined the eect of g-GCS on the activation of NF-kB by PMA, LPS, H 2 O 2 , Figure 4 Eect of g-GCS on the expression of CAT gene linked to NF-kB containing mdr1b promoter. Rat hepatoma cells were transiently transfected with the plasmids MDR-NF-kB-CAT (-243RMICAT) both the wild-type and mutant gene. Then cells were treated with 0.1 nM and 1 nM TNF for 2 h, and assayed for CAT activity as describeed in Materials and methods. Results are expressed as fold activation of the neo-transfected control okadaic acid, and ceramide (Figure 2 ). All ®ve agents activated NF-kB in human promonocytic leukemia U-937 cells (upper panel). All ®ve agents also activated NF-kB in neo-transfected rat hepatoma cells (middle panel), although in some cases the overall activation was less pronounced than in U-937 cell. g-GCS-transfection completely blocked NF-kB activation by PMA and okadaic acid, partially inhibited H 2 O 2 -induced activation and minimally aected LPS-and ceramide-induced activation (lower panel). These results thus suggest that LPS, H 2 O 2 , and ceramide activate NF-kB by a mechanism that is quite dierent from that of PMA and okadaic acid.
g-GCS inhibits TNF-dependent degradation of IkBa and translocation of p65
The translocation of NF-kB to the nucleus is preceded by the phosphorylation and proteolytic degradation of IkBa (Baeuerle and Baichwal, 1997) . We used Western blot analysis to determine whether g-GCS also inhibits IkBa degradation induced by treatment of cells with TNF for dierent times. IkBa was degraded within 15 min of TNF treatment and reappeared by 30 min in hepatoma (neo) cells (Figure 3a) . In g-GCS-transfected cells, however, no degradation of IkBa was observed after TNF treatment even for up to 240 min. Western blot showed that, in contrast to neo-transfected cells, levels of p65 remained high in cytoplasmic extracts of g-GCS-transfected cells (Figure 3b ). The nuclear levels of p65 protein increased in neo-transfected cells but not in g-GCS-transfected cells, thus suggesting that in g-GCS-transfected cells, TNF-induced nuclear translocation of p65 is blocked.
g-GCS blocks NF-kB-dependent reporter gene expression induced by TNF
Our results up to now show that g-GCS blocks the binding of NF-kB protein to DNA and IkBa degradation. A recent report indicates that IkBa degradation and NF-kB DNA binding are insucient for TNF-induced NF-kB-dependent gene transcription (Bergmann et al., 1998) . Whether g-GCS also blocks TNF-induced NF-kB-dependent gene expression was examined. The rat multiple drug resistance (MDR) gene promoter contains an NF-kB binding site. The Figure 5 Eect of expression of g-GCS gene on TNF-dependent activation AP-1. Rat hepatoma cells (2610 6 /ml), nontransfected and transfected with neo and g-GCS genes, were incubated at 378C with 1 nM TNF for dierent times (a) and with dierent concentrations (b) of TNF for 2 h, and then nuclear extracts prepared and assayed for AP-1 as described in Materials and methods g-Glutamylcysteine synthetase suppresses TNF signaling SK Manna et al promoter was ligated with the CAT reporter gene and transfected into neo-and g-GCS-transfected cells; then the cells were stimulated with 100 and 1000 pM TNF. TNF activated CAT activity by 2.5-fold and 6.5-fold at 100 and 1000 pM TNF, respectively in neo-transfected cells, whereas a minimal increase in CAT activity over the basal was observed in g-GCS-transfected cells (Figure 4 ). These eects were speci®c, as the plasmid with a mutated NF-kB binding site was not activated upon treatment of cells with TNF. The dierence noted between neo and g-GCS-transfected cells was not due to the dierence in transfection eciency as transfection of both cell types with pCMV-CAT provided comparable results (data not shown). These results thus demonstrate that g-GCS also blocks TNF-induced transcriptional activity.
g-GCS inhibits TNF-induced AP-1 activation TNF is a potent activator of another transcriptional factor, AP-1 (Westwick et al., 1994) . Several reports indicate that the requirements for AP-1 activation dier from that of NF-kB activation (Meyer et al., 1993; Shenk et al., 1994; Galter et al., 1994) . Therefore, we investigated the eect of g-GCS on TNF-induced AP-1 activation. As shown in Figure 5a , TNF (1000 pM) activated AP-1 in a time-dependent manner. At 60 min activation was ®vefold in neotransfected cells, whereas no activation was observed at 60 min in g-GCS-transfected cells. Only at 240 min was a twofold activation of AP-1 noted in g-GCStransfected cells. TNF also activated AP-1 in a dosedependent manner, with ®vefold activation at 1000 pM in control cells whereas only a twofold activation of AP-1 occurred in g-GCS-transfected cells even with 10 000 pM TNF. This activation was speci®c as it was completely inhibited by the unlabeled probe ( Figure  5b ).
g-GCS inhibits TNF-induced c-Jun kinase activation
TNF is also a potent activator of N-terminal c-Jun kinase (JNK) (Westwick et al., 1994) . This kinase is activated in response to dierent kinds of stress and is needed for activation of AP-1. In addition cytokines are known to activate JNK through generation of ROI (Gomez del Arco et al., 1996; Lo et al., 1996; Wilhelm et al., 1997; Esposito et al., 1994) . As shown in Figure 6a , TNF activated JNK in control cells in a time-dependent manner, with 5 ± 6-fold activation noted with 1000 pM TNF within 5 min. g-GCS transfection, in contrast, almost completely suppressed TNF-induced JNK activation at short time; twofold activation was observed in 15 min. These results thus indicate that glutathione generated by g-GCS downregulates TNF-induced JNK activation.
g-GCS inhibits TNF-induced MAPK kinase activation
It has been reported that TNF activates a serine/ threonine kinase, MAP kinase kinase kinase (also called MEKK) which in turn activates a dualspeci®city kinase, MAP kinase kinase (also called MEK), and that activates another serine/threonine MAP kinase, MAPK/erk. There are reports that MEKK is required for TNF-induced NF-kB activation (Lee et al., 1997) , so whether g-GCS aects TNFinduced activation of MEK was investigated. MEK was activated by TNF in a dose-dependent manner in control cells but not in g-GCS-transfected hepatoma cells (Figure 6b ). These results indicate that activation of MEK by TNF is also suppressed by g-GCSgenerated GSH. The suppression of TNF-induced MEK by g-GCS was speci®c as MKK3, also activated by TNF, was not aected by g-GCS (Figure 6b ). The overexpression of g-GCS also did not aect the activity of p70 S6 kinase, another kinase unaected also by TNF (Figure 6b ).
g-GCS blocks TNF-mediated cytotoxicity and activation of caspase-3
TNF acts as an antiproliferative agent against a wide variety of tumor cells. Thus we also examined the eect of g-GCS transfection on the cytotoxic eects of TNF. MTT assay (mitochondrial activity) showed that g-GCS-transfected cells are completely protected from the cytotoxic eects of TNF ( Figure  7a , upper panel). One hallmark of apoptosis is the activation of caspase-3 activity, which leads to cleavage of PARP substrate from 116 kDa to 85 kDa (Seelig et al., 1984) . TNF induced cleavage of PARP within 1 h in control cells (Figure 7 , lower panel) whereas g-GCS-transfected cells were resistant to PARP cleavage even with 1000 pM TNF treatment. These results thus suggest that g-GCS also blocks TNF-induced activation of caspase-3.
Discussion
In this report we investigated the eect of transfection of cells with the g-glutamyl-cysteine synthetase gene on the cellular responses activated by TNF. Both early (within minutes) and late (in hours) eects of TNF were examined. Early eects included activation of nuclear transcription factors NF-kB and AP-1 and the associated kinases MEK and JNK. The late eects included activation of caspase-3 and antiproliferative response. We found that TNF-induced activation of NF-kB, degradation of IkBa, nuclear translocation of p65, and NF-kB-dependent reporter gene expression were all suppressed by g-GCS transfection. Activation of AP-1, JNK, MEK, and apoptosis induced by TNF were also abrogated.
Just how g-GCS abolishes all these TNF-mediated eects is not clear, but several lines of evidence indicate that it must involve glutathione: g-GCS is a rate- Figure 7 (a) Eect of g-GCS on TNF-induced cytotoxicity as determined by MTT method. Cells (5610 3 /0.1 ml) were treated with dierent concentrations of TNF for 72 h at 378C in a CO 2 incubator and cell viability determined by the MTT method as described in Materials and methods. All determinations were made in triplicate. (b) The eect of g-GCS on TNF-induced caspase-3 activation. Rat hepatoma cells were incubated with dierent concentrations of TNF for 2 h at 378C in the presence of 2 mg/ml cycloheximide. Then the cells were washed and scraped from the plate, extracted, and Western blot performed using anti-PARP monoclonal antibody. The band shown in the ®gure was at 116 kDa, which was degraded into 85 kDa fragment limiting enzyme in the synthesis of GSH, and several reports indicate that treatment of cells with TNF reduces intracellular GSH levels (Ishii et al., 1992; Shoji et al., 1995; Goossens et al., 1995; Phelps et al., 1995; Liu et al., 1998; Kinscherf et al., 1998) and treatments that enhance intracellular GSH levels (Ishii et al., 1992; Goossens et al., 1995; Mehlen et al., 1996; Obrador et al., 1997; Fernandez-Checa et al., 1997; Kinscherf et al., 1998) protect cells from TNFmediated cytotoxicity. Thus one possible mechanism by which g-GCS protects cells from TNF-induced cytotoxicity is through generation of GSH. Elevation of intracellular GSH levels by N-acetyl cysteine is also known to block TNF-induced NF-kB activation Staal et al., 1990; Shreck et al., 1991 Shreck et al., , 1992a , a result consistent with our work.
Though AP-1 activation was blocked by transfection with g-GCS gene, published reports indicate that antioxidants including NAC, PDTC and thioredoxin, will suppress NF-kB activation (Meyer et al., 1993; Schenk et al., 1994; Galter et al., 1994) , themselves activate AP-1. This suggests the two transcription factors are activated by distinct mechanism. It is possible, however, that the upstream pathway required for activation of both NF-kB and AP-1 are similar but the downstream pathways are distinct. Like g-GCS, overexpression of MnSOD is also known to block the TNF-induced activation of both NF-kB and AP-1, suggesting a requirement for superoxide radical for both the transcription factors (Manna et al., 1998) . Indeed, by using¯uorescent probe DHR123, we found that both g-GCS-transfected clones produce substantially reduced levels of ROI (Shoji et al., 1995; Yamane et al., 1998) .
Whether GSH plays any role in TNF-induced activation of JNK and MEK has not previously been reported, but both have been shown to be redoxsensitive Gomez del Arco et al., 1996; Lo et al., 1996; Wilhelm et al., 1997) . Since JNK and MEK have been shown to be involved in activation of AP-1 and NF-kB, respectively (Westwick et al., 1994; Lee et al., 1997) , it is possible that suppression of these kinases by g-GCS generated GSH leads to suppression of the transcription factors. The importance of intracellular GSH for activation of AP-1 has been suggested (Esposito et al., 1994) .
In our study TNF-induced IkBa degradation was also blocked in g-GCS-transfected cells. The degradation of IkBa requires phosphorylation, ubiquitination and proteolytic degradation (Baeuerle and Baichwal, 1997) . Because the ubiquitin-conjugating enzymes are regulated by the redox status of the cell (Obin et al., 1998) , it is possible that inhibition of TNF-induced IkBa degradation by g-GCS is due to the inactivation of ubiquitin-conjugating enzymes.
NF-kB activation by okadaic acid and PMA were inhibited in g-GCS transfected cells, activation by ceramide and LPS was unaected and activation by H 2 O 2 was partially inhibited. These results suggest that the redox status of the cell is not important for NF-kB activation by all agents. This is consistent with a report indicating NAC or dihydrolipoate blocks NF-kB activation by TNF, lymphotoxin and PMA, but not that induced by calyculin A or okadaic acid, both inhibitors of serine/threonine protein phosphatases (Suzuki et al., 1994) . Similarly, lipid peroxidation is involved in the activation of NF-kB by TNF but not by IL-1 (Bowie et al., 1997) . Indeed, IL-1 induces NFkB activation independently of the production of ROI (Manna et al., 1998) . Since the redox status of dierent cell types may vary, it is possible that some of these eects are cell type-dependent. In fact, distinct signal transduction pathways leading to NF-kB induction by IL-1 in epithelial and lymphoid cells have been observed (Bonizzi et al., 1997) .
g-GCS transfection of cells also blocked TNFmediated cytotoxicity and activation of caspase-3, a critical marker of apoptosis. Several recent reports indicate that activation of NF-kB may block TNFmediated apoptosis (Wang et al., 1996; Beg and Baltimore, 1996; Van Antwerp et al., 1996; Liu et al., 1996; Giri and Aggarwal, 1998) . Our results are consistent with the thesis that suppression of NF-kB by g-GCS leads to apoptosis. Other reports, however, demonstrate that activation of NF-kB is independent and not linked to TNF-mediated apoptosis (Cai et al., 1997; Steen et al., 1998) . Some of these dierences may be accounted for by cell type. How NF-kB activation blocks TNF-induced apoptosis has not been clear. Given our results and evidence that the promoter of g-GCS contains NF-kB and AP-1 binding sites and that TNF induces the expression of g-GCS , it is possible that g-GCS is the critical mediator. Recently, it was reported that TNF-induced apoptosis requires JNK activation, which suggests this is the critical pathway (Guo et al., 1998; Roulston et al., 1998) . We, however, show that g-GCS suppresses TNFinduced activation of both JNK and apoptosis. Thus it is likely that there are alternate apoptosis pathways that do not involve JNK. For instance intracellular GSH inhibits TNF-induced neutral sphingomyelinase activation without inhibiting JNK thus blocking TNFinduced apoptosis (Liu et al., 1998) .
Modulation of the TNF-induced apoptosis pathway by g-GCS may well have relevance to resistance to chemotherapy. g-GCS expression has been shown to induce resistance to the cytotoxic eects of alkylating agents and heavy metals including cisplatin, melphalan, chlorambucil, arsenite, and cadmium (Yamane et al., 1998) . In addition, coordinated overexpression of the multidrug resistance-associated protein (MRP) synthetase genes and g-GCS have been found in human colorectal cancers, colon and leukemic cells (Yamane et al., 1998; Kuo et al., 1996) . Similarly, transfection of complementary DNAs for the heavy and light subunits of g-GCS results in resistance to melphalan, and in melphalan-resistant human prostate carcinoma cells g-GCS is up-regulated (Mulcahy et al., 1994 (Mulcahy et al., , 1995 . Why drug-resistant cells overexpress g-GCS is not clear, but there is evidence for altered regulation of g-GCS gene expression in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines (Yao et al., 1995) . Thus it is highly likely that g-GCS plays an important role in development of resistance to cytokines and chemotherapeutic agents by altering the redox status of the cell.
Materials and methods

Materials
Bacteria-derived recombinant human TNF, puri®ed to homogeneity with a speci®c activity of 5610 7 units/mg, was 
Cell lines
Rat hepatoma H4-IIE cells were stably transfected with human g-GCS genes and with neo gene (control) as described in detail elsewhere (Yamane et al., 1998) . Two dierent clones, H9 and H17, transfected with the human g-GCS cDNAs were examined. Clone H9 expressed about ®vefold higher g-GCS mRNA compared to that in the clone H17. When analysed for glutathione content, cells transfected with neo, clone 9 and clone 17 had 1.58+0.1, 2.34+0.28 and 1.97+0.026 nmoles/mg protein, respectively. All transfected cells (neo, H9 and H17) were cultured in DMEM containing 10% FBS and penicillin (100 U/ml), and streptomycin (100 mg/ml) in the presence of 400 mg/ml neomycin. U-937 cells were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). Cells were cultured in RPMI-1640 medium supplemented with 10% FBS, penicillin (100 U/ml), and streptomycin (100 mg/ ml). All cells were free from mycoplasma as detected by GenProbe Mycoplasma rapid detection kit (Fisher Scienti®c, Pittsburgh, PA, USA).
NF-kB activation assays
To determine NF-kB activation, nuclear extracts were prepared and electrophoretic mobility shift assays (EMSA) were carried out essentially as described (Chaturvedi et al., 1994; Schrieber et al., 1989) . Brie¯y, nuclear extracts prepared from TNF-treated cells (2610 6 /ml) were incubated with 32 P end-labeled 45-mer double-stranded NF-kB oligonucleotide (4 mg protein with 16 fmoles DNA) from the HIV-LTR, 5'-TTGTTACAAGGGACTTTCCGCTGGGGA-CTTTCCAGGGA GGCGTGG-3' (bold indicates NF-kB binding sites) for 15 min at 378C, and the DNA-protein complex formed was separated from free oligonucleotide on 6.6% native polyacrylamide gels. A double-stranded mutated oligonucleotide, 5'-TTGTTACAACTCACTTTCCGC TGC-TCACTTTCCAGGGAGGCGTGG-3'), was used to examine the speci®city of binding of NF-kB to the DNA. The speci®city of binding was also examined by competition with the unlabeled oligonucleotide. The dried gels were visualized and radioactive bands quantitated by a PhosphorImager (Molecular Dynamics, Sunnyvale, CA, USA) using Imagequant software.
AP-1 activation assay
To assay the activation of AP-1, 4 ± 5 mg of nuclear extract prepared as indicated above was incubated with 16 fmol of the 32 P-end-labeled AP-1 consensus oligonucleotide 5'-CGCTTGATGACTCAGCCGGAA-3' (Santa Cruz Biotechnology Inc.) (bold indicates AP-1 binding sites) for 15 min at 378C and analysed by EMSA. The speci®city of binding was examined by competition with unlabeled oligonucleotide. Visualization and quantitation of radioactive bands was carried out by a PhosphorImager (Molecular Dynamics) using Imagequant software.
Western blot for IkBa and p65
To determine the levels of IkBa, postnuclear (cytoplasmic) extracts were prepared (Singh and Aggarwal, 1995) from TNF-treated cells and resolved on 9% SDS-polyacrylamide gels. To determine the levels of NF-kB proteins and p65, nuclear and postnuclear extracts prepared from TNF-treated cells were resolved on 9% SDS ± PAGE. After electrophoresis, the proteins were electrotransferred to nitrocellulose ®lters, probed with rabbit polyclonal antibodies against IkBa or p65, and detected by chemiluminescence (ECL, Amersham) (Singh and Aggarwal, 1995) . The bands obtained were quantitated using Personal Densitometer Scan v1.30 and Image Quant software version 3.3 (Molecular Dynamics).
Cytotoxicity assays
The cytotoxic eects of TNF on rat hepatoma cells were determined by the modi®ed tetrazolium salt 3-(4-5-dimethylthiazoyl-2-yl) 2-5-diphenyl-tetrazolium bromide (MTT) assay (Manna et al., 1998) . Brie¯y, cells (5 000 cells/ well) were incubated in the presence or absence of the indicated test sample in a ®nal volume of 0.1 ml for 72 h at 378C. Thereafter, 0.025 ml of MTT solution (5 mg/ml in PBS) was added to each well. After a 2-h incubation at 378C, 0.1 ml of the extraction buer (20% SDS, 50% dimethyl formamide) was added. After an overnight incubation at 378C, the optical densities at 590 nm were measured using a 96-well multiscanner autoreader (Dynatech MR 5000), with the extraction buer as a blank.
Immunoblot analysis of PARP degradation
TNF-induced apoptosis was examined by proteolytic cleavage of PARP (Haridas et al., 1998; Tewari et al., 1995) . Brie¯y, cells (2610 6 /ml) were treated with TNF for dierent times at 378C and then extracted by incubation for 30 min on ice in 0.05 ml buer containing 20 mM HEPES pH 7.4, 2 mM EDTA, 250 mM NaCl, 0.1% NP-40, 2 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mM PMSF, 0.5 mg/ml benzamidine, and 1 mM DTT. The lysate was centrifuged and the supernatant was collected. Cell extract protein (50 mg) was resolved on 7.5% SDS ± PAGE, electrotransferred onto a nitrocellulose membrane, blotted with mouse anti-PARP antibody, and then detected by chemiluminescence (ECL; Amersham). Apoptosis was represented by the cleavage of 116-kDa PARP into a 85-kDa peptide product (Tewari et al., 1995) .
c-Jun kinase assay
The c-Jun kinase assay was performed by a modi®ed method as described earlier (Manna et al., 1998) . Brie¯y, after treatment of cells (3610 6 /ml) with 1 nM TNF at dierent times, cell extracts were prepared by lysing cells in buer containing 20 mM HEPES pH 7.4, 2 mM EDTA, 250 mM NaCl, 1% NP-40, 2 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mM PMSF, 0.5 mg/ml benzamidine, and 1 mM DTT. Cell extracts (150 ± 250 mg/sample) were immunoprecipitated with 0.3 mg anti-JNK antibody for 60 min at 48C. Immune complexes were collected by incubation with protein A/G sepharose beads for 45 min at 48C. The beads were extensively washed with lysis buer (46400 ml) and kinase buer (26400 ml; 20 mM HEPES, pH 7.4, 1 mM DTT, 25 mM NaCl). Kinase assays were performed for 15 min at 308C with GST-Jun (1 ± 79) as a substrate in 20 mM HEPES, pH 7.4, 10 mM MgCl 2 , 1 mM DTT, and 10 mCi [g 32 P]ATP. Reactions were stopped with the addition of 15 ml of 26SDS sample buer, boiled for 5 min, and subjected to SDS ± PAGE (9%). GST-Jun (1 ± 79) was visualized by staining with Coomassie Blue, and the dried gel was analysed by a Phosphorimager (Molecular Dynamics).
g-Glutamylcysteine synthetase suppresses TNF signaling SK Manna et al
MAP kinase kinase assay
Cells, stimulated with dierent concentrations of TNF for 30 min at 378C were washed with Dulbecco's phosphatebuered saline and then lysed with buer containing 20 mM HEPES, pH 7.4, 2 mM EDTA, 250 mM NaCl, 0.1% NP-40, 2 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mM PMSF, 0.5 mg/ml benzamidine, 1 mM DTT, and 1 mM sodium orthovanadate. A 50-mg aliquot of protein was resolved on 10% SDS ± PAGE, electrotransferred to nitrocellulose ®lters, and probed with either the phospho-speci®c anti-p44/42 MAP kinase (Thr 202/Tyr 204), anti-p70 S6 kinase, anti-MKK3 or anti-MAPK antibodies (New England Biolabs, Inc) raised in rabbit (1 : 3000 dilution). Then the membrane was incubated with peroxidase-conjugated anti-rabbit IgG (1 : 3000 dilution), and the bands detected by chemiluminescence (ECL, Amersham).
Transient transfection and CAT assay
The plasmid with insert consisting of rat MDR1b promoter containing either wild-type or mutated NF-kB binding site linked to a chloramphenicol acetyl transferase (CAT) reporter gene (-243RMICAT) has been described previously in detail (Zhou and Kuo, 1997) . To determine the TNFinduced NF-kB mediated CAT reporter gene transcription, hepatoma (neo and GCS) cells were transiently transfected by the calcium phosphate method with the plasmids 243RMICAT (contains wild-type NF-kB binding site) and -243RMICAT-km (mutated binding site), according to the instructions supplied by the manufacturer (Life Technologies). After 12 h of transfection, the cells were stimulated with 100 and 1000 pM of TNF for 2 h, washed, and examined for CAT activity as described (Sambrook et al., 1989) .
Abbreviations TNF, tumor necrosis factor; NF-kB, nuclear transcription factor-kB; IkB, inhibitory subunit of NF-kB; EMSA, electrophoretic mobility shift assay; GCS, glutamylcysteine synthetase; ROI, reactive oxygen intermediate; DTT, dithiothreitol; FBS, fetal bovine serum; CAT, chloramphenicol acetyl transferase; MTT, 3-(4,5-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(1H)-quinolinine; PARP, poly (ADP ribose) polymerase; PMA, phorbol 12-myristate 13 acetate; CD, cytoplasmic domain; BSO, buthionine-L-sulfoximine; PDTC, pyrrolidine dithiocarbamate; NAC, N-acetylcysteine
